• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC NOGA XP CARDIAC NAVIGATION SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC NOGA XP CARDIAC NAVIGATION SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Catalog Number UNK_NOGA XP
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Stroke/CVA (1770); Tachycardia (2095)
Event Date 12/21/2019
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: mathiasen ab, qayyum aa, jørgensen e, helqvist s, kofoed kf, haack-sørensen m, ekblond a, kastrup j.Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the msc-hf trial.Eur j heart fail.2020 may;22(5):884-892.Doi: 10.1002/ejhf.1700.Epub 2019 dec 21.Pmid: 31863561.Objective/methods/study data: the mesenchymal stromal cells- heart failure trial was a phase ii, single-center, randomized, double-blind, placebo-controlled study.The study assessed 4-year outcomes of intramyocardial injections of autologous bone marrow-derived mesenchymal stromal cells in 60 patients with ischemic heart failure, new york heart association class ii¿iii, left ventricular ejection fraction <45% and no further treatment options were treated between april 2009 and september 2008.Patients were randomized 2:1 to intramyocardial injections of mesenchymal stromal cells or placebo.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: noga-xp.Concomitant other biosense webster devices that were also used in this study: myostar injection catheters.Concomitant non-biosense webster devices that were also used in this study: n/a.Adverse event(s) and provided interventions: there were two serious adverse events in relation to the noga procedure: one patient with a history of ventricular tachycardia developed ventricular tachycardia during the noga mapping procedure.The patient reverted to sinus rhythm by his implantable cardioverter-defibrillator unit and the procedure was canceled.One patient experienced double-vision and dizziness during the injection procedure.Cerebral ct afterward was normal, but the incident was diagnosed as a minor stroke by the neurologist.The patient was without sequelae and completed the follow-up.
 
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: mathiasen ab, qayyum aa, jørgensen e, helqvist s, kofoed kf, haack-sørensen m, ekblond a, kastrup j.Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the msc-hf trial.Eur j heart fail.2020 may;22(5):884-892.Doi: 10.1002/ejhf.1700.Epub 2019 dec 21.Pmid: 31863561.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOGA XP CARDIAC NAVIGATION SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14409561
MDR Text Key291741185
Report Number2029046-2022-01029
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeDA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NOGA XP
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/19/2022
Initial Date FDA Received05/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Life Threatening;
-
-